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Cure of hepatoblastoma requires complete macro- and microscopic resection of the tumor, without
tumor rupture. In case of hepatoblastoma with intra-atrial tumor extension (ITE), “en bloc” resection of
the hepatic tumor and ITE, with minimal risk of postoperative liver failure, constitutes a surgical chal-
lenge. We report on a 3 year old child with hepatoblastoma of the right liver lobe, and ITE through the
upper Inferior Vena Cava. Initial chemotherapy (SIOPEL IV HR) induced good response, but tumor per-
sisted inside the right atrium with tight adhesions to the cardiac wall. “En bloc” right extended hepa-
tectomy and removal of the ITE with reconstruction of the atrial and caval wall with autologous
pericardial patch was performed under normothermic extracorporeal circulation and cardioplegia,
combined with in situ hypothermic liver preservation of the remaining left liver. Complete tumor
resection was achieved without tumor rupture. Postoperative liver function was immediately good and
adjuvant chemotherapy was resumed per protocol. Eleven months after the end of treatment the child is
in complete tumor remission. In children with hepatic tumor and ITE, combination of normothermic
extracorporeal circulation with cardioplegia and in situ hypothermic liver preservation allows “en bloc”
extended hepatectomy and removal of ITE, with limited risk of postoperative liver failure.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).The aim of surgery for hepatoblastoma (HB) is complete resec- risk and allow complex liver resections, three techniques of hypo-
tion of the tumor without rupture. If the tumor has an intra-atrial
tumor extension (ITE), combination of hepatobiliary and cardiac
surgical techniques is needed. In case of extended hepatectomy
leaving a small liver remnant, normothermic vascular exclusion
exposes the patient to the risk of postoperative acute liver failure,
which may lead to urgent liver transplantation (LT). To reduce thised tomography; ECC, extra-
othermic liver preservation;
va; LT, liver transplantation;
y Group of the SIOP: Société
r Vena Cava; US, ultrasound.
ardot).
Inc. This is an open access article uthermic liver preservation (HLP) have been described: in situ, ante
situm and ex situ HLP.
The aim of this article is to report on our experience of “en bloc”
resection of a large HB of the right liver with ITE in a 3-year-old
child combining in situ HLP and cardioplegia under normothermic
extracorporeal circulation (ECC).1. Case report
1.1. Case presentation
A 32-month-old male was presented with abdominal pain and
vomiting. Physical examination revealed a large abdominal mass.
Imaging with Ultrasound-Doppler (US) and computed tomographynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. Operation scheme. 1. SVC cannula, 2. SVC clamp, 3. IVC cannula, 4. Portome-
senteric cannula, 5. Infra-hepatic suprarenal IVC clamp, 6. Hepatic pedicle clamp
(Pringle’s maneuver), 7. Right atrium opening for heart and liver remnant drainage,
8. Left atrium drainage cannula, 9. Portal cannula (through right portal stump) for in
situ liver remnant perfusion of 4 C preservation solution, 10. “En bloc” hepatectomy
and ITE resection line.
J. Thalhammer et al. / J Ped Surg Case Reports 12 (2016) 44e49 45(CT) showed a large hepatic tumor of the right liver located in
segments V, VI, VII and I measuring 9.4 9.0 12.8 cm, and a small
satellite lesion of 1.2 cm diameter in segment V (Fig. 1). The main
tumor extended into the right hepatic vein, the Inferior Vena Cava
(IVC) and the right atrium, where its size was 3.5  3 cm. Its left
edge touched the median hepatic vein. Portal branches were free of
tumor. There was no intraperitoneal rupture and no distant
metastasis. Alphafetoprotein level was 384 000 mg/L. Percutaneous
ultrasound guided needle core biopsy conﬁrmed the diagnosis of
HB. Neither portal, nor central venous emboli were observed. The
radiological staging was PRETEXT II V3 according to the Interna-
tional Childhood Liver Tumors Strategy Group (SIOPEL) staging [1].
The patient was treated according to the SIOPEL IV high risk pro-
tocol, using cisplatin and doxorubicin [2]. Due to good tumor
response and poor tolerance to chemotherapy, the third preoper-
ative cycle was skipped.
1.2. Situation at surgery and description of intervention
Eleven weeks after diagnosis CT showed a signiﬁcant reduction
of the main tumor with an estimated volumetric reduction of 90%
(Fig. 1). Nevertheless, tumor persisted in the right atriumwith tight
contact and possible invasion of its posterior wall. Alphafetoprotein
markedly decreased (168 mg/L at day of surgery). The remaining
liver free of tumor included segments II, III, left 2/3 of IV and left half
of I, with left vessels. Its mass was estimated by CT volumetry
between 200 and 250 g, representing 1.5e1.8% of the child’s body
mass.
The operation took place 13 weeks after diagnosis at the age of
35 months (weight 13.35 kg) and can be watched in Video 1. It was
carried out through amedian sternotomy, prolonged by an inversed
T laparotomy. In situ HLP was prepared as follows (Fig. 2): 1) the
inferior mesenteric vein was cannulated up to the splenomesen-
teric conﬂuence; 2) the lower IVC was cannulated up to the renal
veins; 3) the right branch of the portal vein was cut and a cannula
was inserted in its proximal segment toward the left portal vein;
4) the infrahepatic IVC and the suprahepatic IVC were isolated. The
hepatectomy started without vascular exclusion of the liver at the
right border of the common trunk of the median and left hepatic
veins, preserving the left 2/3 of segment IV, and progressed towardFig. 1. Radiological presentation on injected CT of the tumor at diagnosis (AeD) and after 2
was 94  90  128 mm for the main liver tumor and 36  28 mm for the tumor in the rig
tumoral extension to the IVC and the right atrium to 11  11  27 mm.the origin of the right portal pedicle. The lower retrohepatic IVC
was freed from the right liver, which remained attached only by the
right hepatic vein and the ITE (Fig. 3). The superior vena cava (SVC)courses of chemotherapy (SIOPEL IV HR) at the time of surgery (EeH). Size at diagnosis
ht atrium; pre-operatively the main tumor was reduced to 48  40  49 mm and the
Fig. 3. Intraoperative views. A) The hepatectomy has been started without vascular exclusion, and the tumoral right liver remains attached only by the right hepatic vein and ITE.
The heart was then arrested under cardioplegia and normothermic ECC: SVC cannula (star) and aortic cannula (black arrowhead). HLP was achieved by clamping the hepatic pedicle
and infusion of 4 C preservation solution through a cannula inserted in the right portal vein stump (white arrow). The atrium is opened for both cardiac and hepatic outﬂow
drainage. B) Magniﬁcation of the intra-atrial tumor extension (white triangle) on a different view. C) The tumor has been resected “en bloc” with the ITE and the IVC and atrial
vascular wall. D) The right atrium has been reconstructed with an autologous pericardial patch. The heart has been restarted, while the liver remains excluded with the newly
reconstructed suprahepatic IVC clamped.
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installation for ECC. After insertion of a cannula in the AA for car-
dioplegia, the AA and the SVCwere clamped, a cannulawas inserted
in the left atrium for drainage and cardioplegia was started. After
cardiac arrest the diaphragm was opened longitudinally and total
vascular exclusion of the liver was immediately carried out by:
1) clamping of the hepatic pedicle, 2) clamping of the suprarenal,
infrahepatic IVC, 3) opening of the right atrium for drainage and
4) infusion of cold (4 C) preservation solution (Custodiol, EUSA
Pharma, Germany) in the left liver via the right portal cannula. The
drained ﬂuid from the right atrium was not reused. As the ITE
was tightly adherent to the posterior wall of the right atrium, it was
resected “en bloc” with the IVC and ITE, and the hepatectomy was
ﬁnalized (Fig. 3). There was no tumor rupture during the procedure
and the margins weremacroscopically free of tumor. An autologous
pericardial patch was used to reconstruct the right atrium and the
IVC (Fig. 3). The cold perfusion of the liver was stopped and the
remaining left liver was ﬂushed with 300 mL of cold (4 C) 5%
albumin. The newly reconstructed IVC was clamped below the
diaphragm, and the heart was restarted, with the liver remnant still
being under total vascular exclusion. The cardiac function was
immediately good. The HLP perfusion cannula was removed of the
right portal vein stump, and the liver remnant was reperfused by
declamping the infrahepatic IVC, suprahepatic IVC and the hepatic
pedicle. Reperfusion of the liver remnant was immediate and
homogenous and the child was hemodynamically stable: the ECC
was stopped and the remaining cannulas were removed. Heparin
was antagonized with protamine. Two pericardial drains and a left
thoracic drain were placed. Two pairs of electrodes were inserted
on the right atrium and on the left ventricle for further stimulation,
if needed. An immediate postoperative US showed normal vascular
ﬂows in the liver remnant.
Duration of ECC was 110 min, cardioplegia 53 min and liver
remnant cold ischemia time was 66 min. Intraoperative blood
products (including albumin) transfused represented 4.3 times
patient’s total blood volume. Additional ﬂuids administrated during
the procedure represented 1.4 times patient’s total blood volume.
No vasopressors were needed.
1.3. Postoperative course
The postoperative (po) course was almost uneventful, apart
from one recurrent episode of clostridium difﬁcile colitis, and the
child was discharged home on po day 20. Histological examination
of the resected specimen showed completemacro- andmicroscopicresection (R0). Forty percent of the tumor remnant was viable HB,
whose histology was 95% fetal type, 4% embryonic and 1% of small
undifferentiated cells. The ITE was sterilized by chemotherapy. One
month after surgery chemotherapy was resumed as per SIOPEL IV
high risk protocol [2]. Overall tolerance was good. Currently, 11
months after the end of treatment, and 14months after surgery, the
child is alive and well in complete tumor remission with normal
liver function tests.
2. Discussion
2.1. Surgical challenges posed by hepatic tumors with ITE
HB is a malignant tumor whose cure needs surgery aiming at
complete resection without tumor rupture [3e6]. As ITE of HB is
rare, there is no consensus on surgical techniques to remove it.
Goals of surgery must be “en bloc” resection of both tumoral liver
and ITE without tumor rupture, and prevention of postoperative
liver failure. In favorable cases, the ITE is not adherent to the
vascular wall, and shrinks after pre-op chemotherapy: in such
cases, the lower part of the right atrium can be clamped through the
abdominal incision, and the intravascular tumor remnant can be
extracted together with the main hepatic tumor after opening the
IVC. In cases where the intra-atrial tumor remnant is large and/or
adhesion or invasion of the atrial wall is suspected, opening the
right atrium  resection of the vascular wall seems to be the most
cautious option to avoid tumor rupture and spillage, and allow
complete (R0) resection: in such cases cardioplegia is needed.
2.2. Techniques used for hepatic tumors with ITE
In adults, Hepatocellular Carcinoma (HCC) can present with
intravascular extension to the IVC and the right atrium [7]. Tumors
with extension in the IVC can be safely resected with good long
term results using varying degrees of vascular exclusion [8e10].
“En bloc” resection provides a clear survival beneﬁt for adults with
HCC [11,12]. In cases of ITE current recommendation is to start
with hepatectomy and proceed as far as possible before cardiac
surgery, in order to reduce the time of cardioplegia [11]. Since the
upper IVC needs to be opened for such “en bloc” resection, the
perfusion of the liver remnant needs to be interrupted tempo-
rarily, leading to the risk of ischemia-reperfusion injury. To reduce
the risk of normothermic ischemic injury, a standard approach
was cardioplegia combined with general hypothermia [13,14]. The
general hypothermia can be as deep as 18 C and combined with a
Table 1
Reported cases of hepatoblastoma with intra-atrial extension.
Study Age,
gender
Liver extension Intraportal and/or
extrahepatic tumor
apart from ITE
Pre-op
chemo
Type of resection En bloc Cold liver preservation Follow up
Patients who underwent hepatectomy with atrial resection or thrombectomy
Mestres et al.,
1991 [32]
36, M VI to VIII No 3 cycles Right hepatectomy with atrial
resection
Yes General hypothermia
(20 C) with circulatory
arrest
Death po day 21 (probably pulmonary
embolism)
Murakami
et al., 1995
[33]
36, M Local recurrence after
right hepatectomy
No Yes Complementary resection with
atrial resection
No Cardiopulmonary bypass
without liver preservation
Death 12 M post op, intracranial bleeding
due to metastasis
Oldhafer et al.,
2000 [16]
31, ? I þ IV to VIII IVC, right renal
vein, portal vein
3 cycles Extended right hepatectomy
with atrial resection
Presumably no: caval
thrombectomy separately from
the main
tumor
General hypothermia
(20 C) with low-ﬂow
perfusion
Local recurrence; A&W, free of tumor, 10
months after second line treatmenta
Wang et al.,
2002 [34]
27, M Right lobe Lung Portal vein yes Not speciﬁed ? ? Alive 24 M post op; no details available
Wang et al.,
2002 [34]
17, M Right þ left multifocal Lung portal vein yes Not speciﬁed ? ? Death 28 M post op
Freely et al.,
2010 [35]
11, F I to IV No 2 cycles Left hepatectomy with atrial
resection
Yes Hypothermia (32 C) with
cardiopulmonary bypass
No follow up data available
Guérin et al.,
2010 [36]
? All Lung 7 cycles Liver transplant vascular
thrombectomy without atrial
resectionb
Yes R1 resectionb Primary LT ECC without
cardioplegiab
Lung recurrence; A & W, free of tumor, 8
years after second line treatmentb
Lautz et al.,
2011 [37]
8, F PRETEXT IV P2V3
(central), POST-TEXT III
P1V3 (central)
No Yes Non anatomical
resection þ atrial thrombectomy
Not speciﬁed R1 resection Cardiopulmonary bypass
without liver preservation
Liver ischemia Rescue LT (living donor);
A&W, free of tumor, 11 M after LT
Other cases of intra-atrial HB mentioned in literature
Sarper et al.,
2006 [38]
10, ? All segments multifocal Portal vein 8 cycles No resection e e Alive 43 M post diagnosis with residual
disease
Pepelassis et al.,
2007 [39]
25, M ? No Yes ? ? ? No follow-up data available; Shrinkage of
ITEþ reopening of IVC under chemotherapy
Kesik et al.,
2009 [40]
18, M Bifocal: right lobe þ IV
B PRETEXT IV
No 6 cycles Only right hepatectomy as
thrombus resolved
e No A&W, free of tumor 11 M after diagnosis
Huang et al.,
2010 [41]
48, M V to VIII ( IV ?) Lung 2 cycles e e e Death by fungal meningitis related to
Chemotherapy
? : unspeciﬁed
a Local tumor recurrence 6 and 11 months after initial surgery, above the right kidney and below the right diaphragm, treated by 2 further surgical resections, high dose chemotherapy with autologous stem cell trans-
plantation, and local radiotherapy.
b Personal communication with Dr. Florent Guérin: recurrent pulmonary metastasis resected 5 months after LT.
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Oldhafer et al., in children [16]. Although general hypothermia is
commonly used in children for surgery of congenital heart defects,
it increases the risk of bleeding due to coagulopathy [17]. In case of
hepatectomy with liver cut surface, bleeding may be a life
threatening risk after unclamping the liver remnant. To circum-
vent both risks of normothermic liver ischemia and bleeding due
to general hypothermia, in situ HLP has been described in adults
[18,19].
2.3. Techniques to reduce the risk of postoperative liver failure
Postoperative liver failure may be due to: 1) insufﬁcient mass
of the liver remnant, 2) preexisting dysfunction of the liver
parenchyma (for instance in cirrhotic patients), 3) ischemia-
reperfusion injury during the surgical procedure. The “small for
size syndrome” is a well-known complication after LT, when the
graft/patient weight ratio is below 1% [20,21]. After in situ HLP, the
liver remnant is in a similar situation to a liver graft after LT. In our
patient the estimated liver remnant/patient weight ratio was
1.5-1-.8%, which was considered to be adequate after in situ HLP,
but dangerous after prolonged normothermic liver exclusion.
Standard warm ischemia is normally achieved by hepatic pedicle
clamping (Pringle’s maneuver), which signiﬁcantly reduces
intraoperative hemorrhage [22]. However, in our patient cardiac
surgery could have exceeded the standard maximum of 60 min,
and thus putting the cardiac surgeon under pressure. For pro-
longed liver ischemia, Azoulay et al., showed better tolerance to
ischemia by using in situ HLP compared to normothermic vascular
exclusion [23].
2.4. Techniques for hypothermic liver preservation
Selective hypothermic perfusion of the liver has been described
early in the history of liver surgery [24]. There are three main
techniques of isolated (as opposed to systemic) hypothermic
preservation of the liver: ex situ, ante situm and in situ techniques
[25]. Pichlmayer described the method of ex vivo liver surgery,
including total hepatectomy, ex situ preservation of the liver (as for
a liver graft), complex partial hepatectomy, and re-implantation of
the autograft [26]. This technique allows a maximal comfort for
liver surgery (3D mobilization of the liver, no bleeding and reduced
time pressure), but may have severe complications due to vascular
and biliary reconstructions, especially the risk of hepatic artery
thrombosis of the liver remnant [27,28]. Moreover, this technique is
inappropriate, if the whole tumor cannot be removed by total
hepatectomy alone: in case of ITE, the total hepatectomywould lead
to transection of the tumor, which for HB would be equivalent to
tumor rupture. In order to minimize complications of the ex situ
technique, the “ante situm” approach was proposed, in which the
hepatic pedicle is not transected and the liver is perfused with
hypothermic solution in situ via the portal or arterial branch of the
lobe that is resected in direction of the remaining liver, and
drainage via the suprahepatic IVC, which is transected allowing
high organ mobility [29]. However, this technique requires clamp-
ing of the suprahepatic IVC, and therefore cannot be used in case of
atrial tumor extension. The third option is in situ hypothermic
perfusion, in which there is no vascular transection, but only
clamping of the supra- and infra-hepatic IVC. The liver is perfused
as described in the ante situm technique and drained via an incision
of the retrohepatic IVC. This technique can be combined with car-
dioplegia and atrial opening, which obviates the need of supra-
hepatic IVC clamping and allows “en bloc” resection of the hepatic
tumor and its ITE. Based on their own experience and review of the
literature Hoti et al., and Azoulay et al., favor in situ and ante situmtechniques, rather than ex situ surgery: in a review of their expe-
rience and published cases, 23/205 (11.2%) patients died after in situ
and ante situm HLP and none was transplanted; after ex situ HLP
17/62 (27.4%) patients died, and 8 needed salvage LTs of whom 7
eventually died [30,31].
2.5. Review of literature for hepatoblastoma with ITE
The prognosis of HB with intra-atrial extension is dismal in our
review of 12 published cases over the last 25 years, as shown in
Table 1 [16,32e41]. Three patients did not undergo surgery: one
died, two were alive with tumor at last follow-up and presumably
died. Nine patients underwent surgery, four died and ﬁve (42% of
the 12 reported cases) are alive in complete remission with a
follow-up ranging from 10months to 8 years: one after rescue LT for
liver ischemia, two after local or metastatic recurrence requiring
second line treatment, one after right hepatectomy alone (as ITE
resolved under chemotherapy), and one with limited details avail-
able. These results compare poorly with currents results of High
Risk HBs: in the SIOPEL-4 trial [2] high risk patients had a 83%
overall 3-year survival, and complete remission could be achieved
in 46/62 patients (74%). This discrepancy between our reviews of
published cases of HBs with ITE may be related to the continuous
progress in the overall management of HB patients in the last de-
cades, especially the improvement of risk-adapted chemotherapy
regimens [2]. Noteworthy, however, in our review of the published
HBs with ITE, complete resection without tumor rupture was re-
ported in only 3/12 patients, including 1 whose ITE had resolved
under chemotherapy.
3. Conclusion
In situ HLP combined with cardioplegia and normothermic
ECC is a safe technique for surgery of hepatic tumors with ITE in
children, enabling complete “en bloc” resection of the
tumoral liver and the ITE, and reducing the risk of postoperative
liver failure. It diminishes time pressure on both cardiac and
hepatic surgical teams, and avoids the risks of general
hypothermia.
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